Findings from neuroimaging, electrophysiology, genetics, and molecular studies are synthesized to provide an integrated overview of the structural, functional, and neurobiological alterations that underlie major depressive disorder.
Abstract
Major depressive disorder (MDD) is a prevalent and disabling psychiatric disorder characterized by persistent mood disturbances, cognitive impairments, and significant systemic consequences. Despite its substantial clinical burden, diagnosis remains challenging because current approaches rely largely on subjective symptom-based assessments and are complicated by marked biological and clinical heterogeneity. In this review, we synthesize findings from neuroimaging, electrophysiology, genetics, and molecular studies to provide an integrated overview of the structural, functional, and neurobiological alterations that underlie MDD. We discuss abnormalities involving large-scale brain networks, neuroplasticity and stress-related pathways, neuroinflammation, oxidative stress, and neurotransmitter systems, together with their implications for biomarker discovery, patient stratification, and treatment response. Collectively, current evidence implicates both molecular dysregulation and large-scale neural network dysfunction in MDD, although direct evidence linking alterations across these biological levels remains limited. Integrating multimodal biological and neuroimaging approaches may improve diagnostic precision, facilitate personalized therapeutic strategies, and advance the development of biologically informed psychiatry.
Major depressive disorder (MDD) is a common and debilitating condition with limited treatment precision. While brain imaging has linked neural features to MDD diagnosis and treatment response, the underlying circuits and their early modulation by treatment remain unclear. To examine changes in functional connectivity w...
Xiao-Yu Tong, Gregory A. Fonzo, Nancy B. Carlisle et al.· bioRxiv· 2 citations· ⚡1
Neuropsychiatric and neurodegenerative disorders, such as major depressive disorder, bipolar disorder, schizophrenia, Alzheimer's disease, and Parkinson's disease, all show a neuroimmune signature with dysregulated inflammatory cytokine profile and cognitive impairment. Although these deficits are clinically relevant,...
Nuriza Tukiran, Theresa Kolb, L. Maggioni et al.· Brain, behavior, and immunit...· 0 citations
Mental disorders are not attributable to a single chemical imbalance, but they are profoundly shaped by dynamic interactions among neurotransmitters, neuropeptides, neurosteroids, inflammatory mediators, genetic variation, neural circuitry, and environmental experience. This review provides an integrated overview of th...
J. C. Ifenkwe, Otiogha Erowo Udogidi· Global Journal of Advanced R...· 0 citations
This review systematically recapitulates the prevailing pathogenic hypotheses and dissects associated multifaceted neurobiological underpinnings, with key evidence predominantly obtained from preclinical chronic stress rodent models, thereby constructing a holistic landscape of depression pathogenesis.
Bo Zhang, Chuan-Yu Li· Depression and Anxiety· 0 citations
Despite small, heterogeneous studies precluding meta-analysis, symptom-correlated fronto-insular-limbic and precuneus alterations may represent potential biomarkers warranting further investigation of PD.
Ming Yue, Qian Zhang, Ao-Xiang Zhang et al.· Journal of Psychiatry & Neur...· 0 citations
The blood–brain barrier (BBB) is a unique neurovascular interface essential for central nervous system homeostasis. Beyond its classical protective role, accumulating evidence points to the BBB as a dynamic structure actively involved in brain function in health and disease. The present review synthesizes clinical, mol...
I. Rostevanov, O. Damri, A. Azab et al.· Pharmaceuticals· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.